Celia N Sánchez-Domínguez

Dr. Celia N Sánchez-Domínguez

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2020 in Viruses
Verified
Journal Article
Open access
PDF file
Mariel Araceli Oyervides-MuñozMariel Araceli Oyervides-Muñoz
Mariel Araceli Oyervides-Muñoz
Antonio Ali Perez-MayaAntonio Ali Perez-Maya
Antonio Ali Perez-Maya
Celia N Sánchez-DomínguezCelia N Sánchez-Domínguez
Celia N Sánchez-Domínguez
ABAnais Berlanga
Anais Berlanga
MAMauro Antonio-Macedo
Mauro Antonio-Macedo
Maria Lourdes Garza-RodríguezMaria Lourdes Garza-Rodríguez
Maria Lourdes Garza-Rodríguez
Persistent high-risk human papillomavirus (HR-HPV) infections play a major role in the development of invasive cervical cancer (CC), and screening for such infections is in many countries the primary method of detecting and preventing CC. HPV typing can be used for triage and risk stratification of women with atypical squamous cells of undetermined significance (ASC-US)/low-grade cervical lesions (LSIL), though the current clinical practice in Mexico is to diagnose CC or its preceding conditions mainly via histology and HR-HPV detection. Additional information regarding these HPV infections, such as viral load and co-infecting agents, might also be useful for diagnosing, predicting, and evaluating the possible consequences of the infection and of its prevention by vaccination. The goal of this follow-up hospital case study was to determine if HPV types, multiple HPV infections, and viral loads were associated with infection persistence and the cervical lesion grade. A total of 294 cervical cytology samples drawn from patients with gynecological alterations were used in this study. HPV types were identified by real-time PCR DNA analysis. A subset of HPV-positive patients was reevaluated to identify persistent infections. We identified HPV types 16, 18, and 39 as the most prevalent. One hundred five of the patients (59%) were infected with more than one type of HPV. The types of HPV associated with multiple HPV infections were 16, 18, and 39. In the follow-up samples, 38% of patients had not cleared the initially detected HPV infection, and these were considered persistent. We found here an association between multiple HPV infections and high viral loads with and infection persistence. Our findings suggest there are benefits in ascertaining viral load and multiple HPV infections status of HR-HPV infections for predicting the risk of persistence, a requirement for developing CC. These findings contribute to our understanding of HPV epidemiology and may allow screening programs to better assess the cancer-developing risks associated with individual HR-HPV infections.

2 February 2020 in Polymers
Verified
Journal Article
Open access
PDF file
JRJorge A Roacho-Pérez
Jorge A Roacho-Pérez
FRFernando G Ruiz-Hernandez
Fernando G Ruiz-Hernandez
Christian ChapaChristian Chapa
Christian Chapa
HMHerminia G Martínez-Rodríguez
Herminia G Martínez-Rodríguez
Israel Alejandro Flores UrquizoIsrael Alejandro Flores Urquizo
Israel Alejandro Flores Urquizo
Celia N Sánchez-DomínguezCelia N Sánchez-Domínguez
Celia N Sánchez-Domínguez
Some medical applications of magnetic nanoparticles require direct contact with healthy tissues and blood. If nanoparticles are not designed properly, they can cause several problems, such as cytotoxicity or hemolysis. A strategy for improvement the biological proprieties of magnetic nanoparticles is their functionalization with biocompatible polymers and nonionic surfactants. In this study we compared bare magnetite nanoparticles against magnetite nanoparticles coated with a combination of polyethylene glycol 3350 (PEG 3350) and polysorbate 80 (Tween 80). Physical characteristics of nanoparticles were evaluated. A primary culture of sheep adipose mesenchymal stem cells was developed to measure nanoparticle cytotoxicity. A sample of erythrocytes from a healthy donor was used for the hemolysis assay. Results showed the successful obtention of magnetite nanoparticles coated with PEG 3350-Tween 80, with a spherical shape, average size of 119.2 nm and a zeta potential of +5.61 mV. Interaction with mesenchymal stem cells showed a non-cytotoxic propriety at doses lower than 1000 µg/mL. Interaction with erythrocytes showed a non-hemolytic propriety at doses lower than 100 µg/mL. In vitro information obtained from this work concludes that the use of magnetite nanoparticles coated with PEG 3350-Tween 80 is safe for a biological system at low doses.

17 January 2018 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MSMauricio Andrés Salinas-Santander
Mauricio Andrés Salinas-Santander
VICTOR TREVINOVICTOR TREVINO
VICTOR TREVINO
EREduardo de La Rosa‑Moreno
Eduardo de La Rosa‑Moreno
BVB�Rbara Verduzco‑Garza
B�Rbara Verduzco‑Garza
Celia N Sánchez-DomínguezCelia N Sánchez-Domínguez
Celia N Sánchez-Domínguez
RORocio Ortiz-Lopez
Rocio Ortiz-Lopez
Vitiligo is a disorder causing skin depigmentation, in which several factors have been proposed for its pathogenesis: Environmental, genetic and biological aspects of melanocytes, even those of the surrounding keratinocytes. However, the lack of understanding of the mechanisms has complicated the task of predicting the development and progression. The present study used microarray analysis to characterize the transcriptional profile of skin from Vitiligo Vulgaris (VV) patients and the identified transcripts were validated using targeted high‑throughput RNA sequencing in a broader set of patients. For microarrays, mRNA was taken from 20 skin biopsies of 10 patients with VV (pigmented and depigmented skin biopsy of each), and 5 biopsies of healthy subjects matched for age and sex were used as a control. A signature was identified that contains the expression pattern of 722 genes between depigmented vitiligo skin vs. healthy control, 1,108 between the pigmented skin of vitiligo vs. healthy controls and 1,927 between pigmented skin, depigmented vitiligo and healthy controls (P<0.05; false discovery rate, <0.1). When comparing the pigmented and depigmented skin of patients with vitiligo, which reflects the real difference between both skin types, 5 differentially expressed genes were identified and further validated in 45 additional VV patients by RNA sequencing. This analysis showed significantly higher RNA levels of calpain‑3, dopachrome tautomerase, melan‑A and tyrosinase‑related protein‑1 genes. The data revealed that the pigmented skin of vitiligo is already affected at the level of gene expression and that the main differences between pigmented and non‑pigmented skin are explained by the expression of genes associated with pigment metabolism.

5 November 2021 in Life
Verified
Journal Article
Open access
PDF file
JRJorge A Roacho-Pérez
Jorge A Roacho-Pérez
EGElsa Garza-Treviño
Elsa Garza-Treviño
PDPaulina Delgado-Gonzalez
Paulina Delgado-Gonzalez
ZGZuca G-Buentello
Zuca G-Buentello
JDJuan Luis Delgado
Juan Luis Delgado
JIJose Francisco Islas
Jose Francisco Islas
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited treatment options. Conventional treatments involve the non-specific use of chemotherapeutical agents such as 5-FU, capecitabine, gemcitabine, paclitaxel, cisplatin, oxaliplatin, or irinotecan, which produce several side effects. This review focuses on the use of targeted nanoparticles, such as metallic nanoparticles, polymeric nanoparticles, liposomes, micelles, and carbon nanotubes as an alternative to standard treatment for pancreatic cancer. The principal objective of nanoparticles is reduction of the side effects that conventional treatments produce, mostly because of their non-specificity. Several molecular markers of pancreatic cancer cells have been studied to target nanoparticles and improve current treatment. Therefore, properly functionalized nanoparticles with specific aptamers or antibodies can be used to recognize pancreatic cancer cells. Once cancer is recognized, these nanoparticles can attack the tumor by drug delivery, gene therapy, or hyperthermia.

17 August 2021 in Polymers
Verified
Journal Article
Open access
PDF file
APAna Pinilla
Ana Pinilla
PCPaola Y. Carrión-García
Paola Y. Carrión-García
Celia N Sánchez-DomínguezCelia N Sánchez-Domínguez
Celia N Sánchez-Domínguez
Hugo L. Gallardo-BlancoHugo L. Gallardo-Blanco
Hugo L. Gallardo-Blanco
Margarita Sanchez-DominguezMargarita Sanchez-Dominguez
Margarita Sanchez-Dominguez
In the present study, the modification of branched polyethyleneimine (b-PEI) was carried out using mesquite gum (MG) to improve its hemocompatibility to be used in biomedical applications. In the copolymer synthesis process (carboxymethylated mesquite gum grafted polyethyleneimine copolymer (CBX-MG-PEI), an MG carboxymethylation reaction was initially carried out (carboxymethylated mesquite gum (CBX-MG). Subsequently, the functionalization between CBX-MG and b-PEI was carried out using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) as crosslinking agents. The synthesis products were characterized using Fourier transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), and thermogravimetric analysis (TGA). Thermogravimetric analysis showed that CBX-MG and CBX-MG-PEI presented a lower decomposition temperature than MG. The CBX-MG-PEI has a high buffer capacity in the pH range of 4 to 7, similar to the b-PEI. In addition, the CBX-MG-PEI showed an improvement in hemocompatibility in comparison with the b-PEI. The results showed a non-hemolytic property at doses lower than 0.1 µg/mL (CBX-MG-PEI). These results allow us to propose that this copolymer be used in transfection, polymeric nanoparticles, and biomaterials due to its physicochemical and hemocompatibility properties.
1

4 September 2015 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MSMauricio Andrés Salinas-Santander
Mauricio Andrés Salinas-Santander
Celia N Sánchez-DomínguezCelia N Sánchez-Domínguez
Celia N Sánchez-Domínguez
CCCristina Cantú-Salinas
Cristina Cantú-Salinas
HGHugo Gonzalez-Cárdenas
Hugo Gonzalez-Cárdenas
Ana Cecilia Cepeda-NietoAna Cecilia Cepeda-Nieto
Ana Cecilia Cepeda-Nieto
JOJorge Ocampo-Candiani
Jorge Ocampo-Candiani
Alopecia areata (AA) is a skin condition in which hair is lost from certain or all areas of the body. This condition has been described as an immune-mediated complex genetic disease, characterized by the presence of lymphocytes that are directed to the hair follicles in the anagen phase. The gene encoding the protein tyrosine phosphatase, non-receptor type 22 (PTPN22), which is exclusively expressed in immune cells, has been considered as a risk factor associated with a number of autoimmune diseases. In AA, the single nucleotide polymorphism, rs2476601, has been identified as a risk factor in several populations. The aim of the present study was to investigate the effect of PTPN22 C1858T inherited genetic polymorphism on the predisposition to severe forms of AA, in a case-control study on individuals. The study included 64 unrelated patients diagnosed with several types of AA, as well as 225 healthy unrelated subjects. The DNA samples were genotyped for PTPN22 C1858T polymorphism using the polymerase chain reaction-restriction fragment length polymorphism technique. Causal associations were determined by χ2 test and their respective odds ratio (OR) was assessed in a 2×2 contingency table. The results demonstrated a significant association of the T allele [P=0.040; OR=3.196; 95% confidence interval (CI), 0.094–10.279] and the CT genotype (P=0.038; OR=3.313; 95% CI, 1.008–10.892) with patchy AA. In conclusion, the results of the present study suggested the possible involvement of the T allele of the PTPN22 C1858T SNP as a genetic risk factor for this type of AA in the population studied.